# 2026-08-24

Second cycle of the day (19:48 CT). Mode: **dry_run** — no live orders are
possible, and no orders were placed. Dry-run cycle count stands at **1
distinct date** of the 10 required before the live-order gate can open.

## Loss-limit check

Realized P&L is $0.00 today and $0.00 this week against $761.44 starting
capital (0.00% / 0.00%), so new entries and top-ups were **not halted**.

## Positions

No open positions — the account is all cash ($761.44). Nothing to check for
stop-loss, take-profit, or conviction trim this cycle, and there were no
sells.

## Candidates

Phase A re-ran this evening and replaced the proposal file. Of its six
theses, four came back `avoid` (INTC, MRVL, AMD, SPCX) and were not
processed. AAPL was already decided earlier today under the same
proposal date, so idempotency skipped it — its morning approval stands and
was not re-run. That left one candidate:

- **ALH** (new entry, low conviction, `dilution_risk`, 15.5% below its
  52-week high) — **rejected.** Monday's weekend news search turned up
  nothing new for Aug 22–23: the BDT Capital secondary and the Aug 11 Q2
  results are both already inside the thesis, so it was not invalidated.
  The buy gate then blocked it: the price gapped **+4.43%** above the
  thesis-time price ($23.47 → $24.51), over the 3% `entry_price_gap`
  ceiling. The other gate conditions were clear — extension was −5.48%
  against the 20-day average of $25.93, no wash-sale match across the three
  linked accounts, and no sell re-entry lock.

  Worth noting for the human: this cycle ran at 19:45 CT rather than the
  usual 08:35 CT, so the "fresh ask" was an after-hours quote with a wide
  spread (bid $23.12 / ask $24.51) against a $23.84 official close. Most of
  the measured gap is that spread. The gate is mechanical and was applied
  as written — ALH is not blacklisted and gets re-evaluated on the next
  Phase A run.

## Orders

None reviewed, none placed.
